Analyst Ratings for Talaris Therapeutics (TALS)

TALS Rating Summary

  |   Expand Research on TALS
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 4 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/17/2023 H.C. Wainwright Raghuram Selvaraju Downgrade Neutral
(Buy)		 N/A
(N/A)		 1.94
(2.72)		 40.21% Details
7/5/2022 Morgan Stanley
» Updated 9/9/2022		 Vikram Purohit Downgrade Equalweight
(Overweight)		 6.00
(8.00)		 4.51
(2.72)		 -39.69% Details